Adrenomedullin and PAMP: Discovery, structures, and cardiovascular functions

Microscopy Research and Technique

Volumn 57, Issue 1, 2002, Pages 3-13

  Kitamura, Kazuo ^a   Kangawa, Kenji ^b   Eto, Tanenao ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLOGY; DISEASES; PEPTIDES;

BIOLOGICALLY ACTIVE PEPTIDES; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; N-TERMINALS; PATHOPHYSIOLOGICAL CHANGES; PHEOCHROMOCYTOMA; RENAL DISEASE; RESISTANCE VESSELS; STRUCTURE FUNCTIONS;

TISSUE;

ADRENOMEDULLIN; ADRENOMEDULLIN RECEPTOR; AMYLIN; CALCITONIN GENE RELATED PEPTIDE; CYCLIC AMP; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MESSENGER RNA; NITRIC OXIDE; PEPTIDE; PROADRENOMEDULLIN; PROADRENOMEDULLIN N TERMINAL 20 PEPTIDE; PROTEIN KINASE C; RNA POLYMERASE II; TRANSCRIPTION FACTOR AP 2; UNCLASSIFIED DRUG;

ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BODY FLUID; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM; CIRCULATION; ENDOCRINE FUNCTION; GENE STRUCTURE; HEART FAILURE; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY FUNCTION; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN STRUCTURE; RESISTANCE BLOOD VESSEL; SEPTIC SHOCK; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASODILATATION;

EID: 0036127418     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jemt.10052     Document Type: Article

References (96)

1. A cDNA encoding the calcitonin gene-related peptide type 1 receptor
2. Effects of adrenomedullin and proadrenomedullin N-terminal 20 peptide on rat zona glomerulosa cells
3. Peptide secretion: What do we know?
4. Modification of the N- and C-termini of bioactive peptides
5. Shear stress augments expression of C-type natriuretic peptide and adrenomedullin
6. Haemodynamic effects of adrenomedullin in human resistance and capacitance vessels
7. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients
8. Effect of adrenomedullin on renal hemodynamics and functions in dogs
9. Structure-activity relationship of adrenomedullin, a novel vasodilatory peptide, in cultured rat vascular smooth muscle cells
10. Specific receptors for adrenomedullin in cultured rat vascular smooth muscle cells
11. Adrenomedullin and proadrenomedullin N-terminal 20 peptide in impaired renal function
12. A novel putative G protein-coupled receptor highly expressed in lung and testis
13. CGRP-RCP, a novel protein required for signal transduction at calcitonin gene-related peptide and adrenomedullin receptors
14. L-NAME modulates responses to adrenomedullin in the hindquarters vascular bed of the rat
15. The CGTCA sequence motif is essential for biological activity of the vasoactive intestinal peptide gene cAMP-regulated enhancer
16. Molecular cloning of a novel rat G-protein-coupled receptor gene expressed prominently in lung, adrenal, and liver
17. Effects of a synthetic rat adrenomedullin on regional hemodynamics in rats
18. Mechanisms of adrenomedullin-induced vasodilation in the rat kidney
19. Increased circulating adrenomedullin, a novel vasodilatory peptide, in sepsis
20. Molecular forms of circulating adrenomedullin in patients with congestive heart failure
21. Vasodilation and glomerular binding of adrenomedullin in rabbit kidney are not CGRP receptor mediated
22. Adrenomedullin as a novel antimigration factor of vascullar smooth muscle cells
23. Adrenomedullin increases inducible nitric oxide synthase in rat vascular smooth muscle cells stimulated with interleukin-1
24. Transcription factor AP-2 mediates induction by two different signal-transduction pathways: Protein kinase C and cAMP
25. Genomic structure of human adrenomedullin gene
26. Plasma levels of adrenomedullin, a newly identified hypotensivepeptide, in patients with hypertension and renal failure
27. Transcriptional regulation of human adrenomedullin gene in vascular endothelial cells
28. Specific binding sites for proadrenomedullin N-terminal 20 peptide (PAMP) in the rat
29. Renal localization and actions of adrenomedullin: A natriuretic peptide
30. Adrenomedullin as a novel antiproliferative factor of vascular smooth muscle cells
31. Identification of an orphan receptor gene as a type 1 calcitonin gene-related peptide receptor
32. Cloning and expression of cDNA encoding a rat adrenomedullin receptor
33. Receptors for adrenomedullin in human vascular endothelial cells
34. Plasma adrenomedullin in patients with primary aldosteronism
35. Plasma adrenomedullin concentration in patients with heart failure
36. Plasma adrenomedullin and natriuretic peptides in patients with essential or malignant hypertension
37. Expression of the rat adrenomedullin receptor or a putative human adrenomedullin receptor does not correlate with adrenomedullin binding or functional response
38. Short-term modulation of the renin-angiotensin system does not alter plasma adrenomedullin concentration in humans
39. Isolation and characterization of peptides which act on rat platelets, from a pheochromocytoma
40. Adrenomedullin: A novel hypotensive peptide isolated from human pheochromocytoma
41. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin
42. Immunoreactive adrenomedullin in human plasma
43. Identification and hypotensive activity of proadrenomedullin N-terminal 20 peptide (PAMP)
44. Complete amino acid sequence of porcine adrenomedullin and cloning of cDNA encoding its precursor
45. The intermediate form of glycine-extended adrenomedullin is the major circulating molecular form in human plasma
46. Selective inhibition of nicotinic receptors by proadrenimedullin N-terminal 12 peptide in bovine adrenal chromaffin cells
47. Inhibition of endothelin production by adrenomedullin in vascular smooth muscle cells
48. Human proadrenomedullin N-terminal 20 peptide in pheochromocytoma and normal adrenal medulla
49. Visualization of the calcitonin receptor-like receptor and its receptor activity-modifying proteins during internalization and recycling
50. Identification of a protein that confers calcitonin gene-related peptide responsiveness to oocytes by using a cystic fibrosis transmembrane conductance regulator assay
51. Detection of adrenomedullin, a hypotensive peptide, in amniotic fluid and fetal membranes
52. Renal responses to intra-arterial administration of adrenomedullin in dogs
53. Adrenomedullin microinjection into the area postrema increases blood pressure
54. Expression of adrenomedullin in normal human lung and in pulmonary tumors
55. Regulation of insulin secretion and blood glucose metabolism by adrenomedullin
56. Expression pattern for adrenomedullin during pancreatic development in the rat reveals a common precursor with other endocrine cell types
57. Nitric oxide-dependent hypotensive effects of adrenomedullin in rats
58. Adrenomedullin and calcitonin gene-related peptide inhibit aldosterone secretion in rats, acting via a common receptor
59. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
60. Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing
61. The novel vasoactive hormone, adrenomedullin, inhibits water drinking in the rat
62. Dissociation of adrenomedullin concentrations in plasma and cerebrospinal fluid in pregnant and non-pregnant women
63. Hemodynamic, renal, and hormonal effects of adrenomedullin infusion in patients with congestive heart failure
64. Increased plasma levels of adrenomedullin in patients with heart failure
65. Pulmonary vasodilator responses to adrenomedullin are reduced by NOS inhibitors in rats but not in cats
66. Vasodilator effect of adrenomedullin and calcitonin gene-related peptide receptors in rat mesentoric vascular beds
67. Proadrenomedullin N-terminal 20 peptide (PAMP) elevates blood glucose levels via bombesin receptor in mice
68. Genomic organization, expression, and chromosomal mapping of the mouse adrenomedullin gene
69. Adrenomedullin-sensitive receptors are preferentially expressed in cultured rat mesangial cells
70. An abundant and specific binding site for the novel vasodilator adrenomedullin in the rat
71. Cardiovascular actions of adrenomedullin in conscious sheep
72. Central actions of adrenomedullin on cardiovascular parameters and sympathetic outflow in conscious rats
73. Molecular cloning and biological activities of rat adrenomedullin, a hypotensive peptide
74. Distribution and characterization of immunoreactive adrenomedullin in rat tissue and plasma
75. A novel vasoactive peptide, adrenomedullin, inhibits pituitary adrenocorticotropin release
76. Proadrenomedullin N-terminal 20 peptide inhibits adrenocorticotropin secretion from cultured pituitary cells, possibly via activation of a potassium channel
77. Comparison of responses to adrenomedullin and adrenomedullin analogs in the mesenteric vascular bed of the cat
78. Adrenomedullin induces expression of c-fos and AP-1 activity in rat vascular smooth muscle cells and cardiomyocytes
79. Characterization of immunoreactive adrenomedullin in human plasma and urine
80. Adrenomedullin stimulates two signal transduction pathways, cAMP accumulation and Ca mobilization, in bovine aortic endothelial cells
81. Proadrenomedullin NH2-terminal 20 peptide, a new product of the adrenomedullin gene, inhibits norepinephrine overflow from nerve endings
82. A newly identified peptide, proadrenomedullin N-torminal 20 peptide, induces hypotensive action via pertussis toxin-sensitive mechanisms
83. Hypotension and resistance to lipopolysaccharide-induced shock in transgenic mice overexpressing adrenomedullin in their vasculature
84. Endotoxin markedly elevates plasma concentration and gene transcription of adrenomedullin in rat
85. Endothelial cells actively synthesize and secrete adrenomedullin
86. Production and secretion of adrenomedullin from vascular smooth muscle cells. Augmented production by tumor necrosis factor-alpha
87. Effects of vasoactive substances and cAMP related compounds on adrenomedullin production in cultured vascular smoothmuscle cells
88. Evidence for cAMP-independent mechanisms mediating the effects of adrenomedullin, a new inotropic peptide
89. Plasma adrenomedullin in various diseases and exercise-induced change in adrenomedullin in healthy subjects
90. Adrenomedullin: A possible autocrine or paracrine inhibitor of hypertrophy of cardiomyocytes
91. An autocrine or a paracrine role of adrenomedullin in modulating cardiac fibroblast growth
92. Adrenomedullin-immunoreactive neurons in the paraventricular and supraoptic nuclei of the rat
93. Immunohistochemical identification of adrenomedullin in human, rat, and porcine tissue
94. Plasma concentration of human adrenomedullin in patients on hemodialysis
95. Effect of adrenomedullin on aldosteronesecretion by dispersed rat adrenal zona glomerulosa cells
96. Inhibition of aldosterone production by adrenomedullin, a hypotensive peptide, in the rat